Navigation Links
Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal
Date:9/17/2008

WASHINGTON, Sept. 17 /PRNewswire-USNewswire/ -- The Department of Justice announced today that it will not oppose a proposal by the CEO Roundtable on Cancer (CRC) to develop and publicize model contract language for clinical trials of potential new cancer treatments. The Department said the language is not likely to be anticompetitive and can be used to help increase efficiency in contract negotiations, potentially reducing costs and shortening the time needed to begin clinical trials.

The Department's position was stated in a business review letter from Thomas O. Barnett, Assistant Attorney General for the Antitrust Division, to counsel for the CRC.

The CRC and the National Cancer Institute (NCI) will jointly lead the project to develop model language for clinical trials. The CRC is a non-profit organization whose goal is to make continuous progress toward the elimination of cancer as a personal disease and public-health problem. The NCI is the federal government's principal agency for cancer research and training and is part of the U.S. National Institutes of Health.

The CRC requested a business review letter from the Division expressing its enforcement intentions regarding the CRC's and NCI's proposal to develop and publicize model clauses for use in clinical-trial agreements. Clinical-trial agreements typically involve three parties: a pharmaceutical or medical-device company known as a "sponsor"; a hospital, clinic, or university where the research is performed, known as the "research institution"; and the physician who is in charge of the trial, known as the "principal investigator."

"Making the model language available to sponsors, research institutions, and principal investigators, as proposed by CRC, is not likely to reduce competition," Barnett said in the letter. In the letter, Barnett explained that the "model language does not contain any provisions specifying prices or rates," and that "[w]hether to use the langua
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
2. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Chester County Dairy
3. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
4. DuPont Provides Technology for Washington Hospital Centers Emergency Department
5. NYC Department of Healths Get Some NYC Condoms Sends Wrong Message and Misuses Tax Dollars, says MIM President Bob Peters
6. PA Department of Health Reports Rise in Flu Activity; Reminds Public of Need for Flu Shot
7. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
8. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy
9. Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health
10. Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region
11. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) an online ... million in 12% per annum short term debt financing. ... initial drawdown of $500,000, with accrued interest and principal ... with accrued interest and principal repayable in one year ... cashflow positive for any calendar month prior to December ...
(Date:12/16/2009)... 16 EuroPharma, Inc. signs exclusive ... use of super absorbency BCM-95® curcumin and ... The exclusive distribution territory for these ... store channel and professional channel, which includes ... BCM-95® is a highly absorbable curcumin. ...
(Date:12/16/2009)... 16 RealMed has been ranked ... the 2009 Top 20 Best in ... report. RealMed is a dynamic revenue cycle ... processing between healthcare providers and all ... firm specializing in vendor performance measurement in ...
Breaking Medicine Technology:HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3MedImmune to present data on RSV and influenza at 2009 AAP National Conference and Exhibition 59658 1MedImmune to present data on RSV and influenza at 2009 AAP National Conference and Exhibition 59658 2MedImmune to present data on RSV and influenza at 2009 AAP National Conference and Exhibition 59658 3New FDA Study Seeks Feedback on Lasik Surgery 59656 1New FDA Study Seeks Feedback on Lasik Surgery 59656 2Scientists Provide First Map of Complete Human Epigenome 59653 1Scientists Provide First Map of Complete Human Epigenome 59653 2
... Germany, June 5, 2007 – This,year’s American ... sees a wealth of promising new data ... further demonstrating the consistent efficacy and,versatility of ... of metastatic colorectal cancer (mCRC) and squamous ...
... Second Multinational Phase III Study Provides Further ... Inhibition in the Treatment,of Rheumatoid Arthritis, BASEL, ... (1), the second multinational phase III Actemra,(tocilizumab) ... that a greater proportion of patients treated ...
Other Medicine Technology:Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 2Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 3Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 4Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 5Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 6Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 7Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 8New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 2New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 3New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 4
(Date:12/16/2009)... New Enterprise Associates, Inc. (NEA), a ... one of its portfolio companies, Acclarent, Inc., has ... by Ethicon, Inc., a Johnson & Johnson company, ... (net of estimated cash on hand at time ... designing, developing and commercializing devices that address conditions ...
(Date:12/16/2009)... minorities might not gain full benefit from breakthroughs, experts ... embryonic stem cell lines currently used for research come ... , That could mean that non-whites will benefit less ... down the line, experts say. , Blacks could be ... used stem cell lines studied showed any traces of ...
(Date:12/16/2009)... has never felt so good for "The Biggest Loser" ... means continuing to make smart choices everyday to help ... healthy choice that is an important part of living ... Every glass of milk has nine essential nutrients like ... blood pressure, and calcium and vitamin D for strong ...
(Date:12/16/2009)... Dec. 16 For wounded U.S. ... Center in Washington, D.C., the holidays can be a ... to travel home rely more than ever on the ... This week, calling home just got easier for Walter ... calling cards, which will provide hundreds of minutes of ...
(Date:12/16/2009)... As a result of C3: Colorectal Cancer ... reviewed cancer research program is included in the final ... new cancer research program will research cancers, like colorectal ... lung and ovarian cancer research programs run by the ... ,, The $15 million in funding for this new ...
Breaking Medicine News(10 mins):Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 2Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 3Health News:Most Stem Cells Used in Research Come From Whites 2Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3
... to assist in healing, MEMPHIS, Tenn. and ... (NYSE: SNN , LSE: SN) Orthopaedic Trauma ... of the CAPTION(TM),Disposable Platelet Concentration System. The CAPTION ... concentrate (PRC) and eliminates,cross- contamination risks., The ...
... ATLANTA, March 5 ADAMS Management Services Corporation,(ADAMS), ... services,for the healthcare industry, announces the addition of ... the firm,s staff. Ms. Aiken and Mr.,Cannaday have ... Program,Management division of the firm, and are both ...
... Since 1999,OurHealthNetwork.com ( http://www.OurHealthNetwork.com ) has been the,Internet,s ... of board- certified podiatrists now introduces an exclusive ... custom orthotics that not only,provide relief to those ... to their,lifestyles and shoe styles. Now for the ...
... JOLLA, Calif., March 5 DermTech, a biotechnology,company ... and other diseases, today announced that Allan C. ... Halpern is Chief of,Dermatology at Memorial Sloan-Kettering Cancer ... early detection and management of melanoma in high-risk,individuals., ...
... Air Methods Corporation,(Nasdaq: AIRM ) will report financial ... the close of the market on Wednesday, March 12,2008. ... March 12,2008 at 4:15 p.m. Eastern to discuss these ... dialing (888) 396-5640,(domestic) or (706) 643-0580 (international) or by ...
... G-Protein Coupled Receptors, BERWYN, Penn., March 5 ... developing pharmaceutical products targeting G-protein,coupled receptors (GPCRs), today ... financing. Alta Partners and Healthcare Ventures led the ... New Enterprise Associates and,Polaris Venture Partners. The company ...
Other Medicine News:Health News:Smith & Nephew Introduces New Biologic to Speed Healing 2Health News:Smith & Nephew Introduces New Biologic to Speed Healing 3Health News:ADAMS Welcomes Debbie Aiken and Brandon Cannaday to the Firm's Staff as Associate Project Managers 2Health News:ADAMS Welcomes Debbie Aiken and Brandon Cannaday to the Firm's Staff as Associate Project Managers 3Health News:Unique Line of Custom-Made Orthotics for Sandals and Clogs Cater to Style-Minded Foot Pain Sufferers 2Health News:DermTech Adds Allan C. Halpern, MD, Chief of Dermatology at Memorial Sloan- Kettering Cancer Center, to Company's Melanoma Advisory Board 2Health News:Trevena, Inc. Announces $24 Million Series A Financing 2Health News:Trevena, Inc. Announces $24 Million Series A Financing 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: